DD202876A5 - Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen - Google Patents

Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen Download PDF

Info

Publication number
DD202876A5
DD202876A5 DD82242428A DD24242882A DD202876A5 DD 202876 A5 DD202876 A5 DD 202876A5 DD 82242428 A DD82242428 A DD 82242428A DD 24242882 A DD24242882 A DD 24242882A DD 202876 A5 DD202876 A5 DD 202876A5
Authority
DD
German Democratic Republic
Prior art keywords
och
carbon atoms
group
compound
general formula
Prior art date
Application number
DD82242428A
Other languages
German (de)
English (en)
Inventor
Enar I Carlsson
Hakan S Larsson
Sundell Gunhild W Von Wittgen
Ulf K Junggren
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of DD202876A5 publication Critical patent/DD202876A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DD82242428A 1981-08-13 1982-08-11 Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen DD202876A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8104811 1981-08-13

Publications (1)

Publication Number Publication Date
DD202876A5 true DD202876A5 (de) 1983-10-05

Family

ID=20344360

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82242428A DD202876A5 (de) 1981-08-13 1982-08-11 Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen

Country Status (27)

Country Link
US (1) US4746667A (is)
EP (1) EP0074341B1 (is)
JP (1) JPS5839622A (is)
KR (1) KR880001714B1 (is)
AT (1) ATE18765T1 (is)
AU (1) AU556736B2 (is)
CA (1) CA1226223A (is)
CS (1) CS249124B2 (is)
CY (1) CY1450A (is)
DD (1) DD202876A5 (is)
DE (1) DE3270116D1 (is)
DK (1) DK362482A (is)
ES (3) ES514947A0 (is)
FI (1) FI822813L (is)
GR (1) GR76267B (is)
HK (1) HK2189A (is)
HU (1) HU190408B (is)
IE (1) IE54215B1 (is)
IL (1) IL66340A (is)
IS (1) IS1360B6 (is)
MY (1) MY8700139A (is)
NO (1) NO822686L (is)
NZ (1) NZ201538A (is)
OA (1) OA07182A (is)
PH (1) PH18635A (is)
PT (1) PT75420B (is)
ZA (1) ZA825106B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
JO1406B1 (en) * 1984-11-02 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Chemical compounds
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
AR243167A1 (es) * 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ATE103912T1 (de) * 1986-11-13 1994-04-15 Eisai Co Ltd Pyridin-derivate, deren pharmazeutische zusammenstellungen, deren anwendung fuer die herstellung von arzneimitteln mit therapeutischem oder vorbeugendem wert und verfahren zu deren herstellung.
JP2718945B2 (ja) * 1987-06-17 1998-02-25 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
FI96860C (fi) * 1987-06-17 1996-09-10 Eisai Co Ltd Analogiamenetelmä lääkeaineena käytettävän pyridiinijohdannaisen valmistamiseksi
US5223515A (en) * 1988-08-18 1993-06-29 Takeda Chemical Industries, Ltd. Injectable solution containing a pyridyl methylsulfinylbenzimidazole
AT394368B (de) * 1990-08-07 1992-03-25 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von 3,4-dialkoxypyridinen
WO1993024480A1 (en) * 1992-06-01 1993-12-09 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and medicinal use thereof
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
CA2175235A1 (en) * 1993-10-29 1995-05-04 Takeshi Kawakita Pyridine compound and medicinal use thereof
EP0788795B1 (en) 1994-06-10 2002-11-13 Nauchno-Issledovatelsky Institut Farmakologii Akademii Meditsinskikh Nauk Pharmacologically active 2-mercaptobenzimidazole derivatives
US7230014B1 (en) 1997-10-14 2007-06-12 Eisai Co., Ltd. Pharmaceutical formulation comprising glycine as a stabilizer
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
JP5173191B2 (ja) 2004-09-13 2013-03-27 武田薬品工業株式会社 酸化化合物の製造方法及び製造装置
AU2007225935B2 (en) 2006-03-10 2011-12-22 Link Genomics, Inc. Novel pyridine derivative having anti-Helicobacter pylori activity
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
PT2103608E (pt) 2006-12-18 2012-09-24 Arigen Pharmaceuticals Inc Agente de erradicação de helicobacter pylori possuindo uma actividade inibidora na secreção de ácido gástrico
CA2716367C (en) 2008-02-20 2015-05-26 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
RU2484089C1 (ru) * 2009-04-09 2013-06-10 Ариджен Фармасьютикалз, Инк. Тиопроизводное пиридина и фармацевтическая композиция, которая его содержит и имеет способность действовать против helicobacter pylori
US8722026B2 (en) 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
US8992897B2 (en) * 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
AU2013267022B2 (en) * 2010-01-06 2016-04-21 Elc Management Llc Skin lightening compositions
MX2019002726A (es) * 2016-09-14 2019-09-23 Jane Tseng Yufeng Novedosos derivados sustituidos como inhibidores de la d-aminoacido oxidasa (daao).

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7112208A (is) * 1971-09-04 1973-03-06
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (is) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects

Also Published As

Publication number Publication date
US4746667A (en) 1988-05-24
PH18635A (en) 1985-08-23
DE3270116D1 (en) 1986-04-30
IS1360B6 (is) 1989-05-25
IL66340A (en) 1986-08-31
ES8502109A1 (es) 1984-12-16
EP0074341B1 (en) 1986-03-26
ES523344A0 (es) 1984-10-01
FI822813A0 (fi) 1982-08-12
MY8700139A (en) 1987-12-31
ES532044A0 (es) 1984-12-16
OA07182A (fr) 1984-04-30
ZA825106B (en) 1983-04-27
AU8697882A (en) 1983-02-17
HK2189A (en) 1989-01-20
JPH0313203B2 (is) 1991-02-22
KR880001714B1 (ko) 1988-09-08
NO822686L (no) 1983-02-14
PT75420B (en) 1986-12-09
PT75420A (en) 1982-09-01
IL66340A0 (en) 1982-11-30
NZ201538A (en) 1985-12-13
ES8500265A1 (es) 1984-10-01
ES8401482A1 (es) 1983-12-16
EP0074341A1 (en) 1983-03-16
AU556736B2 (en) 1986-11-20
ES514947A0 (es) 1983-12-16
FI822813L (fi) 1983-02-14
IS2749A7 (is) 1983-02-14
DK362482A (da) 1983-02-14
IE821940L (en) 1983-02-13
CY1450A (en) 1989-03-10
CS249124B2 (en) 1987-03-12
IE54215B1 (en) 1989-07-19
JPS5839622A (ja) 1983-03-08
CA1226223A (en) 1987-09-01
KR840001156A (ko) 1984-03-28
HU190408B (en) 1986-09-29
ATE18765T1 (de) 1986-04-15
GR76267B (is) 1984-08-04

Similar Documents

Publication Publication Date Title
DD202876A5 (de) Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen
DE2548340C2 (is)
AU634741B2 (en) Benzimidazole and (4-cyclopropyl methoxy pyridinyl) linked derivatives
DD142882A5 (de) Verfahren zur herstellung von pyridylmethylsulfinylbenzimidazolen
DE3008056C2 (is)
DD252375A5 (de) Verfahren zur herstellung von benzimidazolderivaten
DE3783356T2 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
DE69716904T2 (de) Neue verbindungen
DE2504252A1 (de) Heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende arzneimittel
JPH05507713A (ja) 置換ベンズイミダゾール、その製造方法およびその薬学的使用
DD216929A5 (de) Verfahren zur herstellung von thiazolidinderivaten
DE69908608T2 (de) Derivate von Imidazo[1,2-a]pyridin zur Behandlung von gastrointestinalen Krankheiten
EP0185964A2 (de) Dihydropyridin-carbonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
JPH04502462A (ja) 治療上活性な置換されたベンズイミダゾールおよびその製法
DD201903A5 (de) Verfahren zur herstellung von derivaten des thienopyridonons
AU4813290A (en) Compound with gastric acid inhibitory effect and process for its preparation
DE3618724A1 (de) N-(3-(nitro)-chinol-4-yl)-carboxamidinamide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0045911B1 (de) Neue Aminopropanol-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SK695188A3 (en) Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n-(2- -pyridyl)-2h-thieno (2,3-e)-1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent
DE602004011773T2 (de) Neue imidazopyridinverbindung ii mit therapeutischer wirkung
AT374472B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
AT374473B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
AT375365B (de) Verfahren zur herstellung von neuen 2-pyridylalkyl-sulfinyl-benzimidazolen, von deren hydraten, stereoisomeren und salzen
AT406119B (de) Verfahren zur herstellung von granulaten bzw. tabletten oder kapseln zur oralen verabreichung
AT290536B (de) Verfahren zur Herstellung von neuen Pyridinderivaten

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee